Lots of Maybe's... or perhaps just maybe they did their due diligence and ascertained viability and a market for this product? And of course if the SEC is in the business of shutting down companies with no revenues or an unsuccessful product perhaps we should list at least fifty biotechs for their first assault? I can name several that make reverse splits an annual event and still survive. At any rate you have no stake in this issue other than emotion and opinion, best of luck to you and also to those that have capital riding on the outcome.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.